Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies-Reference-Cited by-同舟云学术

Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies

Published:2018-10 Issue:10 Volume:2 Page:988-996
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

Mitchell Paul,McAllister Ian,Larsen Michael^ORCID,Staurenghi Giovanni,Korobelnik Jean-Francois,Boyer David S.,Do Diana V.,Brown David M.,Katz Todd A.,Berliner Alyson,Vitti Robert,Zeitz Oliver,Metzig Carola,Lu Chengxing,Holz Frank G.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference25 articles.

1. Diabetic retinopathy;Rosenblatt,2009

2. Anti-vascular endothelial growth factor therapy for diabetic macular edema;Boyer;Ther Adv Endocrinol Metab,2013

3. Global prevalence and major risk factors of diabetic retinopathy;Yau;Diabetes Care,2012

4. International Diabetes Federation. IDF Diabetes Atlas. 7th Edition. http://www.idf.org/diabetesatlas. 2017. Accessed June 11, 2017.

5. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE;Nguyen;Ophthalmology,2012

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging Modalities for Assessing the Vascular Component of Diabetic Retinal Disease: Review and Consensus for an Updated Staging System;Ophthalmology Science;2024-05

2. Early Sign of Retinal Neovascularization Evolution in Diabetic Retinopathy;Ophthalmology Science;2024-03

3. Management of Nonproliferative Diabetic Retinopathy: Where Do We Stand?;International Ophthalmology Clinics;2023-12-26

4. Impact of Anti-VEGF Treatment for Diabetic Macular Oedema on Progression to Proliferative Diabetic Retinopathy: Data-driven Insights from a Multicentre Study;2023-11-12

5. Recent advances in the study of circadian rhythm disorders that induce diabetic retinopathy;Biomedicine & Pharmacotherapy;2023-10